Amniotic Fluid Stem Cells: A New Era in Regenerative Medicine

Abstract

Regenerative medicine has become an emerging field which focuses on repair, replacement or regeneration of cells, tissues and the entire organs. The regeneration may occur in patient’s own body by using their system as a bioreactor, e.g., cell therapy that involves transplantation of stem cells capable of proliferating, differentiating and replacing damaged host cells. As the field of regenerative medicine advances, and sources of stem cells has been intensified. Though embryonic and adult tissues can be used for isolation of pluripotent stem cells, the amniotic fluid (AF) has been proposed as an alternative source of stem cells for tissue regeneration. AF cells could be banked and used for either allogeneic or autologous transplantation.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Elliott MJ, De CP, Speggiorin S, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year followup study. Lancet. 2012;380(9846):994–1000.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;1:121–43.

    Article  Google Scholar 

  3. 3.

    Zani A, Cananzi M, Fascetti-Leon F, et al. Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut. 2014;2:300–9.

    Article  Google Scholar 

  4. 4.

    Calvin SE, Oyen ML. Microstructure and mechanics of the chorioamnion membrane with an emphasis on fracture properties. Ann N Y Acad Sci. 2007;1101:166–85.

    Article  PubMed  Google Scholar 

  5. 5.

    Lotgering FK, Wallenburg HC. Mechanisms of production and clearance of amniotic fluid. Semin Perinatol. 1986;10(2):94e102.

    Google Scholar 

  6. 6.

    Cananzi M, Atala A, De CP. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online. 2009;18(Suppl. 1):17–27.

    Article  PubMed  Google Scholar 

  7. 7.

    Gosden C, Brock DJ. Combined use of alphafetoprotein and amniotic fluid cell morphology in early prenatal diagnosis of fetal abnormalities. J Med Genet. 1978;15(4):262–70.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Hoehn H, Bryant EM, Karp LE, et al. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. II. Cytogenetic parameters as functions of clonal type and preparative technique. Clin Genet. 1975;7(1):29–36.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Streubel B, Martucci-Ivessa G, Fleck T, et al. In vitro transformation of amniotic cells to muscle cells—background and outlook. Wien Med Wochenschr. 1996;146(9–10):216–7.

    CAS  PubMed  Google Scholar 

  10. 10.

    De CP, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100–6.

    Article  Google Scholar 

  11. 11.

    Parolini O, Soncini M, Evangelista M, et al. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med. 2009;4(2):275–91.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Bollini S, Cheung KK, Riegler J, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev. 2011;20(11):1985–94.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Angelini A, Castellani C, Ravara B, et al. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. J Heart Lung Transplant. 2011;30(11):1281–93.

    Article  PubMed  Google Scholar 

  14. 14.

    Loukogeorgakis SP, Flake AW. In utero stem cell and gene therapy: current status and future perspectives. Eur J Pediatr Surg. 2014;24(3):237–45.

    Article  PubMed  Google Scholar 

  15. 15.

    Sun H, Feng K, Hu J, et al. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials. 2010;31(6):1133–9.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Piccoli M, Franzin C, Bertin E, et al. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model. Stem Cells. 2012;30(8):1675–84.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Pederiva F, Ghionzoli M, Pierro A, et al. Amniotic fluid stem cells rescue both in vitro and in vivo growth, innervation, and motility in nitrofen-exposed hypoplastic rat lungs through paracrine effects. Cell Transplant. 2013;22(9):1683–94.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Metcalfe AD, Ferguson MW. Bioengineering skin using mechanisms of regeneration and repair. Biomaterials. 2007;28:5100–13.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Alsbjorn B. In search of an ideal skin substitute. Scand J Plast Reconstr Surg. 1984;18:127–33.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19:193–204.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Tsai MS, Lee JL, Chang YJ, et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004;19:1450–6.

    Article  PubMed  Google Scholar 

  22. 22.

    Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007;40(6):936–48.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Pan HC, Yang DY, Chiu YT, et al. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J Clin Neurosci. 2006;13(5):570–5.

    Article  PubMed  Google Scholar 

  24. 24.

    Pan HC, Cheng FC, Chen CJ, et al. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci. 2007;14(11):1089–98.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Ekblad A, Qian H, Westgren M, et al. Amniotic fluid—a source for clinical therapeutics in the newborn? Stem Cells Dev. 2015;24(12):1405–14.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mala Srivastava.

Additional information

Dr. Mala Srivastava, Senior Consultant, Robotic Surgeon in Institute of Obstetrics and Gynaecology at Sir Ganga Ram Hospital, New Delhi; Neha Ahlawat, Research Associate, New Delhi; Dr. Ankita Srivastava, Senior Resident in Department of Obstetrics and Gynaecology at Lok Nayak Jay Prakash Hospital, New Delhi.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Srivastava, M., Ahlawat, N. & Srivastava, A. Amniotic Fluid Stem Cells: A New Era in Regenerative Medicine. J Obstet Gynecol India 68, 15–19 (2018). https://doi.org/10.1007/s13224-017-1034-z

Download citation

Keywords

  • Stem cell
  • Banking
  • Regenerative medicine
  • Amniotic fluid
  • Transplantation
  • Allogenic
  • Autologous